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Abstract: A novel immobilization matrix for the entrapment of viable whole-cell Baeyer–Villiger
monooxygenase was developed. Viable recombinant Escherichia coli cells overexpressing cyclohexanone
monooxygenase were entrapped in polyelectrolyte complex beads prepared by a two-step reaction of
oppositely-charged polymers including highly defined cellulose sulphate. Immobilized cells exhibited
higher operational stability than free cells during 10 repeated cycles of Baeyer–Villiger biooxidations of
rac-bicyclo[3.2.0]hept-2-en-6-one to the corresponding lactones (1R,5S)-3-oxabicyclo-[3.3.0]oct-6-en-3-one
and (1S,5R)-2-oxabicyclo-[3.3.0]oct-6-en-3-one. The morphology of polyelectrolyte complex beads was
characterised by environmental scanning electron microscopy; the spatial distribution of polymers in the
beads and cell viability were examined using confocal laser scanning microscopy, and the texture was
characterised by the mechanical resistance measurements.
Keywords: polyelectrolyte complex beads; environmental scanning electron microscopy; confocal laser
scanning microscopy; Baeyer-Villiger biooxidation; cyclohexanone monoxygenase; immobilization;
viable whole-cell biocatalyst
1. Introduction
The immobilization of viable whole-cell biocatalysts has long been considered an important
method for ensuring their recyclability and stabilisation for the development of the industrial
production of chemical specialities and chiral drug precursors [1]. In particular, the combination of
viable recombinant cells with overproduced enzymes and their immobilization facilitates recyclability
and renders possible a continuous bioreactor arrangement with high application potential [2].
One of the validated techniques for immobilizing viable recombinant cells is their encapsulation in
polyelectrolyte complex (PEC) capsules, which afforded promising results in the previous development
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of encapsulated viable whole-cell biocatalysts [3–5]. PEC capsules have been produced by a single-step
polyelectrolyte complexation of oppositely-charged polyanion (PA) aqueous solutions consisting of
cellulose sulphate (CS), high-viscosity sodium alginate and living bacterial cells with a polycation
solution of poly(methylene-co-guanidine) (PMCG), CaCl2 as gelling and NaCl as antigelling agents [6].
PA microdrops have been air-stripped by a coaxial nozzle into a polycation solution flowing in
a multiloop chemical reactor for the preparation of spherical and monodispersed PEC capsules [7].
This encapsulation protocol preserved the high viability of the encapsulated recombinant Escherichia coli
(E. coli) cells with overproduced ezymes from the group of Baeyer–Villiger monooxygenases (BVMOs)
as well as their long-term storage and operational stability [4,8–10].
The development of encapsulation techniques, including the PEC capsules, has progressed
towards a precise and targeted characterisation of the morphology, physicochemical properties
of capsules, biocompatibility and their changes over time, using the latest techniques [11,12]
for applications in biotechnology and medicine. Additionally, there is also an increased effort to
optimise immobilization by predicting and modelling the bioengineering parameters of potential
industrial processes [13]. On the other hand, current practice in industrial applications of immobilized
biocatalysts [14] does not entail the consistent characterisation of the immobilization procedure and
influence over the geometry, size, stability of composition, mechanical and diffusion properties
of immobilized cell particles. This could lead to an incomplete knowledge of the immobilization
parameters and methods for their control as well as the unsubstantiated exclusion of promising
immobilization techniques for industrial use. The current development and production of tailor-made
CS is crucial for further research into innovative and improved PEC capsules [15]. Parameters such as
the origin of cellulose, molecular weight (MW), viscosity and degree of substitution (DS) of the CS
significantly influence the successful formation of PEC capsules. Hence, the selection of commercial,
tailor-made CS by the process described in [15], which, to the best of our knowledge, alone meets the
latter scientific requirements, is essential for the encapsulation of cells. Although the production of PEC
capsules with semipermeable membranes has been useful for the development of viable whole-cell
biocatalysts under laboratory conditions, it entails a relatively complex encapsulation procedure and
considerable consumption of PMCG and washing solutions using a continuous, one-step protocol.
In addition, for more robust uses, PEC capsules with immobilized whole-cell biocatalysts have proved
to be fragile during intensive mixing [10], and it was necessary to use fluidised-bed bioreactors [5]
or mini packed-bed reactors with a low flow-rate [9]. Hence, it is desirable to develop protocols for the
preparation of PEC beads with enhanced mechanical properties, with a lower consumption of PMCG
and washing solutions, and with a simpler cation immobilization procedure.
The present work sought to develop PEC beads with entrapped viable cells complexed in the
whole volume of the beads. Another aim was the use of imaging techniques to characterise the
morphology of PEC beads and cells in the native state, the spatial distribution of the polymer within
PEC beads and the mechanical resistance of the PEC beads. Viable recombinant E. coli (Escherichia coli)
cells overproducing cyklohexanone monooxygenase (CHMO) from the group of BVMOs were used as
a model biocatalyst in this study. Currently, there is increased interest in research into novel enzymes
and the industrial applications of BVMOs, as they catalyse the enantioselective BV biooxidation
of a wide range of cyclic ketones to the corresponding lactones as chiral precursors of natural and
bioactive compounds as well as potential drugs [16–19]. The study also sought to determine the
operational stability of PEC beads with immobilized recombinant E. coli cells with CHMO during
repeated Baeyer–Villiger (BV) biooxidations as well as the influence of repeated biotransformations on
the viability of cells.
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2. Results and Discussion
2.1. Production of PEC Bads with Immobilized E. coli Containing CHMO
The development of PEC beads was performed following a modified protocol originally developed
for the one-step encapsulation of viable E. coli cells with overproduced BVMO in PEC capsules [4,9].
In the present work, PEC beads were prepared by a two-step procedure. This included the gelation
of PA microdrops with cells in a solution of CaCl2 in the first step followed by polyelectrolyte
complexation with PMCG in the second step, and finally washing in a physiological saline solution.
This immobilization protocol resulted in less stringent and simpler conditions including higher utility
and approximately a 2-fold decrease in the consumption of expensive PMCG and washing solutions for
the preparation of immobilized viable E. coli with CHMO as compared with the PEC capsules previously
used [9]. Use of the two-step procedure for the preparation of PEC beads led to an approximately
one-third cost reduction as compared with the previous production of PEC capsules. Irrespective of this,
a narrow size distribution of PEC beads of 0.64 ± 0.03 mm (Figure 1), high cell viability as well as higher
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Figure  1.  Photomicrography  of  uniform  polyelectrolyte  complex  (PEC)  beads  with  entrapped 
recombinant  E.  coli  (Escherichia  coli)  cells  with  overexpressed  cyklohexanone  monooxygenase 
(CHMO). The immobilization yield was 100%. The scale bar is 1 mm. 
2.2. Suitability of Cellulose Sulphate 
The  selection  of  suitable  CS  as  the  polyanion  component  is  the  key  to  polyelectrolyte 
complexation with the PMCG polycation, which is crucial for the integrity, mechanical and chemical 
resistance and biocompatibility of PEC beads. CS with a DS of 1.45 and a molecular weight of 400,000 
g/mol–500,000 g/mol was used for  the preparation of  the PEC beads using a  two‐stage procedure 
including gelation and complexation steps. The substitution did not apparently depolymerise  the 
cellulose, because  the DS of 1.45 was  in good agreement with  the  increase  in MW of  the starting 









Figure 1. Photomicrography of uniform polyelectrolyte complex (PEC) beads with entrapped
recombinant E. coli (Escherichia coli) cells with overexpressed cyklohexanone monooxygenase (CHMO).
The immobilization yield was 100%. The scale bar is 1 mm.
2.2. Suitability of Cellulose Sulphate
The selection of suitable CS as the polyanion component is the key to polyelectrolyte complexation
with the PMCG polycation, which is crucial for the integrity, mechanical and chemical resistance and
biocompatibility of PEC beads. CS with a DS of 1.45 and a molecular weight of 400,000 g/mol–
500,000 g/mol was used for the preparation of the PEC beads using a two-stage procedure including
gelation and complexation steps. The substitution did not apparently depolymerise the cellulose, because
the DS of 1.45 was in good agreement with the increase in MW of the starting cellulose (254,700 g/mol).
The crystallinity index of the bleached kraft pulp (BKP) CrI of 50 ± 3%, determined by the method
developed by [20] showed a relatively high proportion of the amorphous phase distorted by the
supra-molecular structure of the starting cellulose. If a similar crystallinity is exhibited by the spruce
sulphite pulp (SSP) used in this work, a relatively high proportion of the amorphous phase should afford
a more homogeneous distribution of substitution in the over-molecular cellulose structure. The amorphous
phase also affords the availability of the polycations (PMCG) forming the PEC complex as well as better
permeability of substrates and products for a biocatalytic reaction in that part of PEC beads in which the
CS is incorporated.
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2.3. Repeated Biotransformations Using Immobilized Cells
Stabilisation of the high enzyme activity of cells to achieve the maximum substrate conversion in
repeated biotransformation cycles is one of the most important parameters in respect of the profitability
of immobilized whole-cell biocatalysts [1]. At the same time, when using live cells, the need to maintain
the highest degree of cell viability is also important. Over the course of 10 repeated BV biooxidations
of bicyclo[3.2.0]hept-2-ene-6-one to regioisomeric lactones (1R,5S)-3-oxabicyclo-[3.3.0]oct-6-en-3-one
and (1S,5R)-2-oxabicyclo-[3.3.0]oct-6-en-3-one, a high and stable conversion rate was observed using
E. coli cells with CHMO immobilized in PEC beads (Figure 2). For up to 8 cycles, conversion rates
of 100–93 ± 4% were achieved. After the 9th and 10th cycles, decreases to 85 ± 6% and 65 ± 5%,
respectively were observed. In contrast with these findings, unprotected free cells exhibited a distinct
decrease of 85 ± 6% in substrate conversion of the BV biooxidation in the 4th cycle, which showed
a steady decline to 48 ± 6% in the 10th cycle. Cell stabilization within mild and physiological
microenvironment of the PEC beads may contribute to higher stability of immobilized cells and
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Figure  2. Conversion  of  bicyclic  substrate  to  enantiomerically  pure  lactones  using  free  and  PEC 
immobilized E. coli cells containing CHMO enzyme catalysing Baeyer–Villger BV biooxidation. The 
graph  shows  the  conversion  rate  in  reaction  time  of  120 min. PEC: polyelectrolyte  complex; BV: 
Baeyer–Villiger. 
2.4. Morphology of PEC Beads   











Figure 2. Conversion of bicyclic substrate to enantiomerically pure lactones using free and PEC
immobilized E. coli cells containing CHMO enzyme catalysing Baeyer–Villger BV biooxidation.
The graph shows the conversion rate in reaction time of 120 min. PEC: polyelectrolyte complex;
BV: Baeyer–Villiger.
2.4. Morphology of PEC Beads
To investigate the morphology of the PEC beads, the confocal laser scanning microscopy
arrangement described in the previous section was used (Figure 3). The beads contained Rhodamine
123 and Eosin Y as fluorescent tracer dyes of a concentration of 10−6 mol/L and were incubated
for 15−30 min. These two non-covalently bound fluorescent tracer dyes were employed to monitor
the distribution of the residual opposite charge within the PEC microcapsule [21]. Anionic Eosin Y
(Figure 3A) was predominantly localised in the outer region of the PEC bead, and its concentration
dropped sharply towards the bead interior. On the other hand, cationic Rhodamine 123 (Figure 3B)
was observed in the entire volume of the PEC bead, with a higher intensity at the outer region and
a lower intensity in the centre. Unlike in the previous study on polyelectrolyte capsules [21], no specific
layers or internal structures were observed in the present study. It is worth noting that the spatial
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distribution of the fluorescence reflects the concentration of the dye molecules, corresponding to the

















after  10  biotransformation  cycles;  2:  PEC  beads  prior  to  biotransformations;  3:  free  cells  after  10 
biotransformation cycles; 4: free cells prior to biotransformations. 
Figure 3. Image of PEC beads obtained by confocal laser scanning microscopy. Visualisation of the
spatial distribution of fluorescence of Eosin Y (A) and Rhodamine 123 (B); Profiles of fluorescence
intensity distribution, estimated along the white line for the respective tracer dye (C,D).
2.5. Cell Viability
Cell viability prior to and after biotransformation was measured by the intake of PI by the necrotic
cells [8]. The viability of immobilized cells of E. coli with CHMO under different conditions and after
10 repeated biotransformation cycles (Figure 4) was evaluated. The viability in all cases remained
within an 85−95% range.
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Figure 4. Viability of recombinant E. coli cells with CHMO in different preparations. 1: PEC beads
after 10 biotransformation cycles; 2: PEC beads prior to biotransformations; 3: free cells after
10 biotransformation·cycles; 4: free cells prior to biotransformations.
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The high viability of cells immobilized in PEC beads was identical with that of free cells prior to
biotransformations. This demonstrates the excellent biocompatibility of the novel PEC beads and
their ability to preserve the physiological microenvironment for immobilized cells. At the same
time, the nontoxicity of the PEC complex with CS in capsules [22] was also confirmed in the PEC
beads developed in the present work. In addition, the high cell viability which did not vary
after 10 biotransformation cycles demonstrates the preservation of the physiological conditions for
immobilized cells during biotransformations.
2.6. Environmental Scanning Electron Microscopy (ESEM)
The PEC beads with and without E. coli cells showed a very regular spherical shape with
a relatively smooth surface free from cracks and corrugations that was maintained after repeated
biotransformations (Figure 5A–C). E. coli cells in their native state covered with a very thin liquid
layer of a solution are shown in Figure 5D. The PEC bead microstructure was significantly improved
compared with the microstructure described in a previous study, where the roughness of the PEC
capsule surface with Gluconobacter oxydans cells was higher [5]. A slight wrinkling of the PEC bead
surface without cells is commonly formed during polyelectrolyte complexation (highlighted by white
dashed arrows in Figure 5A). In all cases, good roundness and bead regularity as well as low size
distribution were demonstrated using ESEM. A slightly blurred image of E. coli cells partially covered
by a small layer of the solution exhibited the unique possibility to depict fully wet cells in their
native state using the ESEM AQUASEM II (Figure 5D) equipped with custom-built detectors of signal
electrons with a very high detection efficiency [23]. A lower quality of this image was caused by the
unprocessed state of these live cells, depicted without the use of any preparation technique such as
chemical fixation, drying or metal coating [24] as well as their imaging under a very low beam current
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coli  cells  prior  to  biotransformations  (B),  PEC  bead with  10%  (w/v)  of wet  E.  coli  cells  after  10 
biotransformation  cycles  (C),  free  live  E.  coli  cells  (D)  in  aqueous  solution  of  phosphate  buffer 




Figure 5. Microstructure of PEC bead surface free from cells (A), PEC bead with 10% (w/v) of
wet E. coli cells prior to biotransformations (B), PEC bead with 10% (w/v) of wet E. coli cells after
10 biotransformation cycles (C), free live E. coli cells (D) in aqueous solution of phosphate buffer
recorded by environmental scanning electron microscopy (ESEM) AQUASEM II with highlighted
circularity and diameter measurement (black lines). The surface corrugation is due to cells clustering
(A, white dashed arrow). The scale bar indicates 200 µm in (A–C) and 2.5 µm in (D).
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2.7. Mechanical Resistance
Figure 6 depicts a typical course of the force during measurement of the mechanical resistance
of PEC beads. The point marked by the arrow represents the bursting force required for mechanical
disruption of the PEC bead. The average bursting force of PEC beads with entrapped cells prior
to biotransformations was 0.95 ± 0.04 g/bead, which was close to the average bursting force of
1.16 ± 0.26 g/bead obtained for PEC beads after 10 biotransformation cycles. Practically the same
mean values of bursting force prior to and after biotransformations showed that the mechanical
strength of the PEC complex in the beads was not influenced either by mechanical forces induced by
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Figure 6. Time evolution of compression force applied onto a single PEC bead with immobilized cells
after the 10th biotransformation cycle, measured during mechanical resistance test. The arrow indicates
the moment of bead disruption.
It is also important to note that the PEC complex found throughout the volume of PEC beads
provides additional mechanical resistance to the cells compared with the previously reported PEC
capsule which contains the PEC membrane and the liquid core [25]. This can be seen in the course of
the compression force where, after the disruption of a PEC bead at the point indicated by the arrow,
a small decrease in the force occurred, followed by an increase in the bead resistance. On the other
hand, the bursting of the PEC capsule observed previously [25] was followed by a sharp drop in force
caused by the immediate and irreversible PEC capsule collapse.
3. Materials and Methods
3.1. Characterisation Polymers
High-viscosity, high-mannuronic acid sodium alginate from ISP Alginate (Girvan, UK) with
the following chemical composition (determined by 1H NMR) was employed: fraction of alginate
consisting of guluronic acid FG = 0.41, fraction of alginate consisting of mannuronic acid FM = 0.59;
fractions of alginate consisting of dimers and trimers of gluronic acid (G) and mannuronic acid
(M): FGG = 0.21, FGM = FMG = 0.20, FMM = 0.39; FGGM = FMGG = 0.03, FMGM = 0.18, FGGG = 0.18,
NG>1 = 8. PMCG from Scientific Polymer Products Inc. (Ontario, NY, USA), supplied as a 35% (w/v)
aqueous solution, was lyophilised prior to use. The fluorescent tracer dyes Rhodamine 123 and
Eosin Y were obtained from Acros Organics (Geel, Belgium). Water-soluble CS with the required DS,
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dynamic viscosity and MW was provided by Senova Biotechnologieunternehmen (Weimar, Germany).
The derivative was prepared in accordance with the literature by the homogeneous conversion of
spruce sulphite pulp (MWCuen 254, 700 g/mol from Borregaard ChemCell, Sarpsborg, Norway)
with SO3-pyridine complex in the ionic liquid 1-butyl-3-methylimidazolium chloride (BMIMCl) with
N,N-dimethylformamide as a dipolar aprotic co-solvent in order to improve the miscibility of the
reaction mixture [15]. The final product had a DS of 1.45 and a dynamic viscosity of 15.6 mPa·s in 0.9%
NaCl aqueous solution. The viscosity average molecular weight of around 500,000–600,000 g/mol
corresponds to the weight average molecular weight of CS in the range from 310,000 to 460,000 g/mol
determined by size exclusion chromatography [15]. These values were similar to those of the starting
cellulose of 254,700 g/mol [15]. Sharp peaks characteristic of CS originating from sulphate groups
were observed at 1256 cm−1 (δ SO2) and 805 cm−1 (δ SO).
A Flash 2000 CHNS/O Analyser (Thermo Fisher Scientific, Waltham, MA, USA) was used for
elemental analyses. The DS was calculated from the elemental composition as described in the
literature [15]. Size exclusion chromatography (SEC) of CS was performed on a JASCO system (PU-980
isocratic pump, RI-930 refractive index detector, Suprema guard column and columns (100 Ǻ, 1000 Ǻ,
3000 Ǻ, in series) with 1 M Na2HPO4 (pH = 9, 200 mg/L NaN3) as eluent (flow-rate: 1 mL/min,
sample, concentration: 0.5 mg/mL). A viscometer (Brookfield Programmable DV-II+ Instrument,
Middleboro, MA, USA) equipped with Thermostat Julabo F12 (Seelbach, Germany) was employed
to determine the dynamic viscosity of CS solutions in an 0.9% NaCl aqueous solution. The viscosity
average molecular weight of CS was determined from the intrinsic viscosity in 0.5 M NaCl at 25 ◦C
(Mark Houwink parameters: α = 0.94, K = 6.37·10−6 mL/g) in accordance with the literature [26].
Fourier-transform infra red (FTIR) spectra were measured using a Nicolet 6700 spectrometer (Thermo
Fisher Scientific, Waltham, MA, USA) equipped with DTGS detector and Omnic 8.0 software (Thermo
Fisher Scientific, Waltham, MA, USA). The spectra were collected in the range from 4000 cm−1 to
400 cm−1 at a resolution of 4 cm−1; the number of scans was 128. Diamond Smart Orbit ATR accessory
was applied to solid-state measurements.
3.2. Cultivation of Cells
Cell stocks of E. coli overexpressing CHMO (EC1.14.13.22) from Acinetobacter calcoaceticus
NCIMB 9871 were stored at −80 ◦C. The recombinant E. coli strain was kindly donated by
Prof. Marko D. Mihovilovič (TU Vienna, Austria). Cells, streaked at LBamp agar Petri dish containing
10 g/L of peptone, 5 g/L of yeasts extract, 10 g/L of NaCl, 15 g/L of agar and 0.2 g/L of ampiciline,
were cultivated in an incubator at 37 ◦C to afford colonies of approximately 1 mm size. A single colony
from LBamp agar was inoculated to a 10 mL of LBamp medium in an Erlenmayer flask and allowed
to grow at 37 ◦C in an orbital shaker at 150 rpm for 12 h. 1% of the inoculum (v/v) was pipetted into
a TBamp medium and cultivated at 37 ◦C in an orbital shaker at 150 rpm for 12 h. The addition of
isopropyl β-D-1-thiogalactopyranoside (IPTG) to the final concentration of 0.25 mM to the medium,
during shaking at 25 ◦C in an orbital shaker at 200 rpm for 2 h, induced the synthesis of CHMO
enzyme. The biomass was separated from the medium by centrifugation at 15 ◦C and 4000× g for
15 min and used for biotransformation experiments and immobilization.
3.3. Preparation of Polyelectrolyte Complex Beads
A suspension of cells was prepared in a solution of 1.8% (w/v) of PA consisting of 0.9% (w/v) of
sodium alginate and 0.9% of CS in 0.9% (w/v) NaCl at pH = 7 to the final concentration of 10% of wet
cells. The PA solution with the cells was added dropwise into a stirred gelation solution of 1.0% (w/v)
of CaCl2 using a custom-made coaxial air-stripping extrusion device. The time of gelation was 10 min
and the collection time was 1 min. Subsequently, the prepared beads were separated from the gelation
medium and transferred into a stirred solution containing 1.8% (w/v) of PMCG and 0.9% (w/v) of NaCl
at pH = 7 for 10 min in order to undergo polyelectrolyte complexation. The polyelectrolyte complex
beads were washed with 0.9% (w/v) of NaCl and used in biotransformation.
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3.4. Repeated Biotransformations
PEC beads with immobilized cells (10% w/w) and free E. coli cells were transferred into
a reaction medium containing 50 mM phosphate buffer (pH = 7), 0.2 g/L of ampiciline and 4 g/L of
glucose. Model Baeyer–Villiger biooxidation resulting in the production of lactone regioisomers
(1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one and (1R,5S)-3-oxabicyclo-[3.3.0]-oct-6-en-2-one [27] was
initiated by the addition of substrate rac-bicyclo[3.2.0]hept-2-en-6-one in ethanol (volume ratio 1:9) to
the reaction medium to a final concentration of 0.5 g/L. The reaction conditions were 25 ◦C and 150 rpm
in an orbital shaker. Substrate and produced lactones in samples were extracted in dichlormethane
with methyl benzoate as internal standard (0.5 mg/mL) and analysed using gas chromatography as
reported previously [9]. After each biotransformation, the PEC beads containing cells, and the free
cells, were separated from the reaction medium by filtration (encapsulated cells) or centrifugation
(free cells), washed with a substrate-free medium and subjected to another biotransformation cycle.
3.5. Confocal Laser Scanning Microscopy
The internal structure of the PEC beads was characterised using confocal laser scanning
microscopy (CLSM). Images of the PEC beads were recorded simultaneously in transmission, reflection
and fluorescence modes using a laser scanning microscope head LSM 510 META on Axiovert 200M
stand (both from Carl Zeiss, Jena, Germany). A Zeiss PlanApochromat 10x/0.45 lens was used to
visualise the whole beads. Laser lines of 488 nm for Rhodamine 123 and 543 nm for Eosin Y were used
for excitation. Two channels with band-pass filter 500–550 nm for detection of the reflected light and
a long-pass filter LP 560 nm were used for fluorescence.
3.6. Cell Viability
The CLSM confocal laser scanning microscopy system described for the investigation of the PEC
bead structure was also used for cell viability imaging. Cells necrosis was detected using fluorescence
of propidium iodide by LSM 510 META NLO microscope (Carl Zeiss, Jena, Germany) equipped with
the C-Apochromat 40xW/corr water immersion objective. Viability of the encapsulated cells was
determined after mild disruption of the beads in a test tube. The mixture was carefully stirred so
as to ensure that the remains of beads did not affect the measurement. The cells were incubated for
10 min with 1 µM of propidium iodide (PI). Fluorescence was initiated by the 543 nm line of HeNe
laser and an LP 560 nm long-pass emission filter was used for PI fluorescence detection. The cell
viability was evaluated as a ratio of the number of the surviving bacterial cells to the total number of
bacterial cells. The number of viable bacterial cells was calculated as the difference between the total
number of bacterial cells and the number of necrotic cells identified by propidium iodide fluorescence.
The total number of cells was counted from the respective transmission image in accordance with the
literature [8].
3.7. Environmental Scanning Electron Microscopy
Due to the very high sensitivity of PEC beads to electron beam irradiation resulting in
radiation damage and a high risk of surface dehydration, images of the beads were recorded under
conditions of carefully controlled and very slowly reduced relative humidity (from 100% to 90%) in
a specimen chamber of the ESEM AQUASEM II developed by the group of Environmental Electron
Microscopy (ISI ASCR in Brno, Czech Republic) in cooperation with TESCAN (Brno, Czech Republic).
A sophisticated hydration system with heated needle valve (35 ◦C) was used as an additional water
supply in the microscope. PEC beads and E. coli cells were observed in a small droplet of aqueous
solution of 50 mM phosphate buffer (pH = 7), ampicillin 0.2 g/L and glucose 4 g/L, at a reduced beam
accelerating voltage of 10 kV and very low beam current of 30 pA. A specially modified ionisation
detector of secondary electrons [28] affording a low beam current observation with a large field of
view (up to 850 µm) was used.
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3.8. Mechanical Strength
The mechanical properties of the PEC beads were determined in compression mode using
a Texture Analyser TA-XT2i (Stable Micro Systems, Godalming, UK) equipped with a mobile probe
and Texture Expert Exceed 2.64 software (Stable Micro Systems, Godalming, UK). Compression
measurements were conducted at a compression speed of 0.5 mm/s to the point at which 95% of
50 PEC beads per batch were deformed. The bursting force is the result of this compression test.
4. Conclusions
This work focused on the development of an immobilization procedure providing PEC beads for
the entrapment of viable recombinant E. coli cells with overexpressed cyclohexanone monooxygenase.
Uniform and stable PEC beads were successfully produced by a two-step procedure including
ionotropic gelation and polyelectrolyte complexation. The PEC beads were prepared under less
stringent conditions with a lower consumption of polycation and washing solutions than for the PEC
capsules previously used. These characteristics are highly advantageous for a potential production
scale-up of Baeyer–Villiger biooxidations using entrapped viable cells. Accordingly, it was important
that the performance of cells entrapped in PEC beads for a model Baeyer–Villiger biooxidation,
expressed as their operational stability, was enhanced over that of free cells. The PEC beads
preserved high cell viability and enabled faster and more precise handling with cells during repeated
Baeyer–Villiger biooxidations. Further studies using environmental scanning electron microscopy
confirmed the stability of the dimensions and the sphericity of the PEC beads. In addition, both the
surface morphology and the mechanical resistance of the PEC beads remained unchanged prior to and
after biotransformations.
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and Peter Gemeiner conceived and designed the experiments, and wrote the paper; Alica Vikartovská contributed
reagents/materials/analysis tools; Igor Lacík, Vilém Neděla, Dušan Chorvát and Martin Gericke conceived and
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